The patients’ perspective in oral cancer – part I
Around 370.000 people worldwide are diagnosed with oral cavity cancer each year.[1] Although this is a significant amount, there is little awareness of the symptoms
20 January 2021
News
Read more
Intraoperative assessment has a significant improvement on adequate tumour removal
A recent and very well-built study by the Erasmus-university Medical Center by R. Smits et al. demonstrates that intraoperative assessment has a significant impact on the
30 December 2020
MarginGuide – 3 simple steps to adequate tumor resection
Globally, over 350.000 patients are diagnosed with oral cavity cancer each year. For these patients, the primary treatment is surgery. The surgeon then tries to
23 December 2020
Raising awareness for cancer in the Head & Neck region
Head & Neck cancer is the seventh most common type of cancer in Europe[1]. Head & Neck cancer includes o.a. Oral Cavity Cancer. More than 75%
2 October 2020
Specimen-driven intraoperative assessment of resection margins should be standard of care for oral cancer patients
The Erasmus-university Medical Center recently published a review on the methods for intraoperative margin assessment. The review recommends the specimen-driven approach, which corresponds with the
18 September 2020
Anand Manichand joins SurGuide B.V. as Development and Commercial lead
Anand Manichand, takes on the role of Development and Commercial lead and thereby strengthens the team of SurGuide, a Rotterdam based MedTech start-up. In his
14 September 2020
